Koichi Amano Selected Research

Immunoglobulins (Immunoglobulin)

1/2021

Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Amano Research Topics

Disease

51	Rheumatoid Arthritis 04/2022 - 12/2002
16	Vasculitis (Vasculitides) 08/2022 - 11/2015
13	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 09/2015
8	Infections 02/2022 - 12/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 01/2007
6	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2020 - 01/2012
5	Glomerulonephritis 08/2022 - 03/2019
5	Microscopic Polyangiitis 01/2021 - 11/2016
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 11/2016
3	Fever (Fevers) 10/2019 - 09/2005
3	Neoplasms (Cancer) 07/2018 - 12/2002
3	Lupus Nephritis 01/2013 - 01/2007
2	Osteonecrosis (Kienbock's Disease) 01/2022 - 01/2009
2	Hemorrhage 01/2021 - 01/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2019
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2019 - 10/2017
2	Adult-Onset Still's Disease 03/2018 - 03/2012
2	Congenital Abnormalities (Deformity) 12/2015 - 07/2007
2	Opportunistic Infections (Opportunistic Infection) 07/2013 - 12/2002
1	Herpes Zoster 04/2022
1	Type IV Ehlers-Danlos Syndrome 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Blood Vessel Dissection 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021
1	Nephrosclerosis 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Necrosis 01/2020
1	Systemic Vasculitis 03/2018
1	Lymphoma (Lymphomas) 01/2018
1	Epstein-Barr Virus Infections 01/2018
1	Liver Diseases (Liver Disease) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Jaundice (Icterus) 01/2017
1	Vascular Diseases (Vascular Disease) 10/2015
1	Acute Disease 01/2014
1	Pneumocystis Infections 07/2013
1	Latent Tuberculosis 07/2013
1	Hypersensitivity (Allergy) 07/2013

Drug/Important Bio-Agent (IBA)

21	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2009
17	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 12/2004
15	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 09/2016
9	Biological ProductsIBA 05/2022 - 01/2009
9	Infliximab (Remicade)FDA Link 01/2020 - 01/2005
8	Abatacept (Orencia)FDA Link 01/2021 - 09/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 12/2002
7	GlucocorticoidsIBA 01/2021 - 01/2007
7	Tumor Necrosis Factor InhibitorsIBA 01/2016 - 04/2012
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 09/2005
4	GLPG0634IBA 04/2022 - 01/2022
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 09/2005
4	Rituximab (Mabthera)FDA Link 01/2021 - 12/2017
4	Monoclonal AntibodiesIBA 01/2020 - 01/2009
4	Etanercept (Enbrel)FDA Link 10/2015 - 12/2002
3	Peroxidase (Myeloperoxidase)IBA 08/2022 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2012
3	Antirheumatic Agents (DMARD)IBA 12/2020 - 01/2006
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2009
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2013 - 02/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 01/2009
2	Adalimumab (Humira)FDA Link 02/2022 - 06/2012
2	SteroidsIBA 01/2022 - 12/2002
2	C-Reactive ProteinIBA 01/2021 - 10/2019
2	tofacitinibIBA 01/2021 - 01/2017
2	CytokinesIBA 10/2015 - 06/2003
2	mizoribineIBA 11/2014 - 01/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2007 - 09/2005
2	bucillamine (SA 96)IBA 01/2006 - 01/2005
1	omega-Chloroacetophenone (Mace)IBA 04/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	IntegrinsIBA 01/2021
1	CreatinineIBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	EpitopesIBA 01/2021
1	VaccinesIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	InterferonsIBA 01/2020
1	sifalimumabIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019
1	baricitinibIBA 07/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	CollagenIBA 10/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2014
1	AntigensIBA 07/2013

Therapy/Procedure

17	Therapeutics 01/2021 - 06/2003
8	Remission Induction 01/2021 - 11/2016
2	Drug Therapy (Chemotherapy) 03/2018 - 01/2017
1	Retreatment 01/2014